Indeed, IL-6 is associated with aggressive PCa phenotypes and may be involved in the metastatic process via the regulation of epithelial-mesenchymal transition (EMT) and the homing of cancer cells to the bone [325]. Here, IL6 is linked to posterior cortical atrophy.